Gene · 404663
Papers2,471
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,471
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Detoxified synthetic bacterial membrane vesicles as a vaccine platform against bacteria and SARS-CoV-2. | J Nanobiotechnology | 2023 | 37208676 | PubTator, text mining | PubMed |
| Nanoscale clustering of mycobacterial ligands and DC-SIGN host receptors are key determinants for pathogen recognition. | Sci Adv | 2023 | 37205764 | PubTator, text mining | PubMed |
| Identification of a seven-lncRNAs panel that serves as a prognosis predictor and contributes to the malignant progression of laryngeal squamous cell carcinoma. | Front Oncol | 2023 | 37205188 | PubTator, text mining | PubMed |
| FBXW7β loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth. | Signal Transduct Target Ther | 2023 | 37202390 | PubTator, text mining | PubMed |
| LvCD14L Acts as a Novel Pattern Recognition Receptor and a Regulator of the Toll Signaling Pathway in Shrimp. | Int J Mol Sci | 2023 | 37175476 | PubTator, text mining | PubMed |
| An Isoxazoloquinone Derivative Inhibits Tumor Growth by Targeting STAT3 and Triggering Its Ubiquitin-Dependent Degradation. | Cancers (Basel) | 2023 | 37173892 | PubTator, text mining | PubMed |
| Oncolytic viruses: Narcissistic or altruistic arsonists? | Mol Ther Oncolytics | 2023 | 37168933 | PubTator, text mining | PubMed |
| De novo protein design by inversion of the AlphaFold structure prediction network. | Protein Sci | 2023 | 37165539 | PubTator, text mining | PubMed |
| PcTrim prevents early infection with white spot syndrome virus by inhibiting AP1-induced endocytosis. | Cell Commun Signal | 2023 | 37158899 | PubTator, text mining | PubMed |
| Single-Cell, High-Content Microscopy Analysis of BK Polyomavirus Infection. | Microbiol Spectr | 2023 | 37154756 | PubTator, text mining | PubMed |
| The ribosomal S6 kinase 2 (RSK2)-SPRED2 complex regulates the phosphorylation of RSK substrates and MAPK signaling. | J Biol Chem | 2023 | 37149146 | PubTator, text mining | PubMed |
| Kinetic investigation reveals an HIV-1 Nef-dependent increase in AP-2 recruitment and productivity at endocytic sites. | bioRxiv | 2023 | 37131815 | PubTator, text mining | PubMed |
| The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses. | Oncogene | 2023 | 37095257 | PubTator, text mining | PubMed |
| Naive T cells inhibit the outgrowth of intractable antigen-activated memory T cells: implications for T-cell immunotherapy. | J Immunother Cancer | 2023 | 37072346 | PubTator, text mining | PubMed |
| TEAD1 trapping by the Q353R-Lamin A/C causes dilated cardiomyopathy. | Sci Adv | 2023 | 37058558 | PubTator, text mining | PubMed |
| A Lipidated Single-B-Chain Derivative of Relaxin Exhibits Improved In Vitro Serum Stability without Altering Activity. | Int J Mol Sci | 2023 | 37047588 | PubTator, text mining | PubMed |
| Photodegradable by Yellow-Orange Light degFusionRed Optogenetic Module with Autocatalytically Formed Chromophore. | Int J Mol Sci | 2023 | 37047499 | PubTator, text mining | PubMed |
| Demonstration of a Plasmonic Nonlinear Pseudodiode. | Nano Lett | 2023 | 37043888 | PubTator, text mining | PubMed |
Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus. | Heliyon | 2023 | 37035348 | PubTator, text mining | PubMed |
| Enhancer of zeste homolog 2 promotes renal fibrosis after acute kidney injury by inducing epithelial-mesenchymal transition and activation of M2 macrophage polarization. | Cell Death Dis | 2023 | 37029114 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/404663/papers?page=10